The University of Geneva continues to test the Ebola virus vaccine

The Geneva University Hospital (HUG) based in Switzerland on January 5 announced it will continue testing an Ebola virus vaccine after a pause due to a notice of side effects. desire from some volunteers. Tests will resume from January 2015.

The vaccine was produced by Canadian public health authorities and licensed to two US companies, NewLink and Merck. This vaccine was previously tested in monkeys and now needs to be tested on humans. According to HUG, the vaccine is also being tested in the US, Canada, Germany and Gabon. The first results will be published in March 2015.

Medical staff transferred the body of a person who died from an Ebola virus infection in Monrovia, Liberia.(Source: AP)

The University of Geneva temporarily stopped testing new vaccines since December 11, 2014 because four cases of mild joint pain in the arms and legs were reported after being vaccinated for 10 to 15 days.

Regarding the Ebola situation, the World Health Organization (WHO) also updated the latest data on January 5, showing that the number of deaths from Ebola virus in West Africa reached 8,153 cases in total. 20.656 cases of infection.

Most of the infections and deaths were recorded in 3 West African countries with the most severe epidemics. As of January 3, Sierra Leone still leads countries with outbreaks with 9,772 infected cases, including 2,915 deaths. Guinea, where the disease broke out a year ago, recorded 2,769 infections and 1,767 deaths. Although the Ebola epidemic is the strongest, Liberia in the past few weeks has witnessed a sharp decrease in the number of infections with 8,115 cases and 3,471 deaths as of December 31, 2014.

In other regions of the world, Mali recorded six deaths, one in the United States and eight in Nigeria. Spain and Senegal have claimed to extinguish the Ebola epidemic when each country has only one case of infection and no case of death. He announced the first case confirmed to be infected with Ebola virus after returning from Sierra Leone. The health of this patient is critical but not worse. In the US and Germany, two medical staff are being monitored in the hospital after returning from Sierra Leone.